Maternal serum screening.

Abstract

Maternal serum screening (MSS) measures three serum markers: alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol, from which the risk of fetal Down syndrome or open neural tube defect is calculated. Initially, 8% of women will have positive results. I present a protocol for investigating these women. Family physicians should be informed about MSS so they can give their patients information and guidance.

• Authors: J C Carroll
• Journal: Canadian family physician Medecin de famille canadien (Can Fam Physician) Vol. 40 Pg. 1756-64 (Oct 1994) ISSN: 0008-350X [Print] Canada
• PMID: 7524838 (Publication Type: Journal Article)

Chemical References

• Chorionic Gonadotropin
• alpha-Fetoproteins
• Estriol

Topics

• Algorithms
• Amniocentesis
• Chorionic Gonadotropin (blood)
• Down Syndrome (blood)
• Estriol (blood)
• Female
• Fetal Diseases (blood)
• Humans
• Maternal Age
• Neural Tube Defects (blood)
• Pregnancy
• Prenatal Diagnosis (methods)
• Risk Factors
• Ultrasonography, Prenatal
• alpha-Fetoproteins (analysis)